Jointly provided by
|
This activity is supported by an independent educational grant from Dexcom, Inc.
|
Monday, April 12, 2021
6:30 PM - 8:00 PM ET
|
|
The virtual symposium has ended. Encore live webcasts will be held at the below times:
Wednesday, May 5, 2021
12:30pm - 2:00pm ET
and
Wednesday, May 19, 2021
12:30pm - 2:00pm ET
To register for one of these webcasts, please visit:
www.managedcarecgm.com/webcasts2021
|
|
Learn About
|
- The value of health technology and remote patient monitoring for type 1, type 2, and gestational diabetes
- How the impact of rtCGM pharmacy coverage on payer management interventions relates to member access and overall cost of care
- The potential for rtCGM to improve diabetes performance measures via hypoglycemia risk reduction, improved HbA1c, and reduced resource utilization
|
Expert Faculty Presenters
|
|
|
|
|
Jeffrey Dunn, PharmD, MBA
Head of Clinical Pharmacy
Berkshire Hathaway/Geico (formerly Haven, the Amazon, Berkshire Hathaway, JPMorgan Chase healthcare venture)
Formerly VP, Clinical Strategy and Programs and Industry Relations
Magellan Rx Management
|
|
Maria Lopes, MD, MS
Former Chief Medical Officer
Magellan Health
|
|
Janet B. McGill, MD, MA, FACE, FACP
Professor of Medicine
Washington University School of Medicine
|
|
Vanita Pindolia, PharmD, BCPS, MBA
Vice President, Ambulatory Clinical Pharmacy Programs_PCM
Henry Ford Health System/Health Alliance Plan of Michigan
|
|
|
|
Who Should Attend?
|
This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of the AMCP, and other managed health care professionals attending AMCP 2021 virtually.
|
|
Statement of Need/Program Overview
|
Diabetes remains a leading cost driver for payers and employers, characterized by insulin spend, hospitalization, and ER utilization. System-wide incentives to prescribe and access real-time continuous glucose monitoring (rtCGM) aligns with a patient-centered approach for managing diabetes-related outcomes and costs.
Pharmacy benefit coverage and access for CGM for appropriate sub-populations can confer immediate cost savings via channel efficiencies and lower acquisition costs. Furthermore, rtCGM has the potential to improve diabetes-specific performance and outcome measures in members with type 1, type 2, and gestational diabetes.
|
|
Educational Objectives
|
At the conclusion of this activity, participants should be able to demonstrate improved ability to:
- Characterize the value of health technology and remote patient monitoring as part of a comprehensive management strategy for diabetes to improve glycemic outcomes
- Discuss the positive impact of rtCGM pharmacy coverage on payer management interventions, provider administrative burden, member experience and access, and overall cost of care
- Review the potential of rtCGM to improve diabetes performance measures via hypoglycemia risk reduction, improved HbA1c, and reduced resource utilization with case scenarios (e.g., pregnancy; senior populations)
|
|
Agenda
|
Date and Time
Monday, April 12, 2021
6:30 PM - 8:00 PM ET
|
|
6:30 PM
|
Opening Comments/Overview
Jeffrey Dunn, PharmD, MBA
|
|
6:35 PM
|
Improving Outcomes and Reducing Resource Utilization with rtCGM Among Medicare Beneficiaries and Other Aging Member Populations
Janet B. McGill, MD, MA, FACE, FACP
|
|
6:50 PM
|
Pharmacy Benefit Integration of rtCGM: Real-World Experience and Cost-Savings from a Regional Health System
Vanita Pindolia, PharmD, BCPS, MBA
|
|
7:10 PM
|
New Horizons in rtCGM and Diabetes Management Programming Across At-Risk Populations: High-Quality, Cost-Effective Care in Gestational and Neonatal Settings
Maria Lopes, MD, MS
|
|
7:30 PM
|
Telemedicine and Digital Health Interventions Integrating rtCGM in the Future of Patient-Centered Diabetes Care
Jeffrey Dunn, PharmD, MBA
|
|
7:50 PM
|
Audience Q&A Session
|
|
8:00 PM
|
Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation
|
|
Physician Credit
Medical Education Resources, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy Credit
 |
Medical Education Resources, Inc. (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA0003680-9999-21-180-L01-P
This activity is certified as Knowledge-based CPE.
|
Continuing Nursing Education
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This CE activity provides 1.5 contact hours of continuing nursing education.
Provider approved by the California Board of Registered Nursing, Provider Number 12299, for 1.5 contact hours.
Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources, Inc. to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.
Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.
|
|
